Skip to main content
. 2014 Sep-Oct;30(5):1072–1076. doi: 10.12669/pjms.305.5170

Table-III.

Cox regression analysis of VEGF polymorphisms with the PFS and OS of osteosarcoma patients

Genotype PFS
HR (95%CI) 1 P value OS
HR (95%CI) 1 P value
Event % Event %
+1612A/G GG 66 38.60 1.0(Ref.) - 45 38.79 1.0(Ref.) -
GA 76 44.44 0.72(0.39-1.35) 0.28 51 43.97 0.8(0.45-1.43) 0.42
AA 29 16.96 0.56(0.25-1.24) 0.12 20 17.24 0.71(0.33-1.51) 0.34
A allele 208 60.82 1.0(Ref.) - 141 60.78 1.0(Ref.) -
G allele 134 39.18 0.74(0.50-1.08) 0.1 91 39.22 0.83(0.57-1.19) 0.29
-634G/C CC 68 39.77 1.0(Ref.) - 45 38.79 1.0(Ref.) -
CT 86 50.29 0.69(0.38-1.26) 0.2 59 50.86 0.86(0.49-1.50) 0.56
TT 17 9.94 0.58(0.23-1.53) 0.22 11 9.48 0.69(0.27-1.75) 0.4
C allele 222 64.91 1.0(Ref.) - 149 64.22 1.0(Ref.) -
T allele 120 35.09 0.48(0.31-0.72) <0.001 81 34.91 0.66(0.45-0.97) 0.03
+936T/C TT 100 58.48 1.0(Ref.) - 69 59.48 1.0(Ref.) -
TC 59 34.50 0.66(0.36-1.19) 0.13 40 34.48 0.75(0.43-1.31) 0.28
CC 12 7.02 0.32(0.13-0.81) 0.006 7 6.03 0.36(0.12-0.96) 0.03
T allele 259 75.73 1.0(Ref.) - 178 76.72 1.0(Ref.) -
C allele 83 24.27 0.56(0.37-0.85) 0.004 54 23.28 0.63(0.42-0.95) 0.02

1. Adjusted for sex, age, tumor location, metastasis and therapy.